With $3.2M in funding, Histolix has developed a cutting-edge technology that enables direct-to-digital diagnosis of tissue
July 14, 2023
Introducing Histolix, the groundbreaking startup founded by visionary entrepreneur Rob Royea. Located in the vibrant city of Sacramento, Histolix is revolutionizing the field of medical devices with its novel point-of-care histopathology solution. With $3.2M in funding, Histolix has developed a cutting-edge technology that enables direct-to-digital diagnosis of tissue in surgery suites and at the clinical point-of-care, providing high-quality digitized images for rapid diagnosis. By eliminating the need for time-consuming histologic procedures and delivering same-day patient diagnosis, Histolix aims to reduce the requirement for additional surgical procedures and provide a slide-free pathology solution.
Led by experienced healthcare industry executives and in collaboration with renowned pathology researchers from the University of California, Davis, Histolix is poised to disrupt the field of digital pathology and revolutionize tissue histology. Don't miss the opportunity to join founder Rob Royea on this groundbreaking journey of innovation and growth.